Back
Denali Therapeutics Stock Price Chart
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
41
DNLI
Denali Therapeutics
Last Price:
17.14
Seasonality Move:
-0.16%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- The current trend is relatively stagnant and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.88 | Buy |
| 20-day SMA: | 16.9 | Buy |
| 50-day SMA: | 18.87 | Sell |
| 200-day SMA: | 20.37 | Sell |
| 8-day EMA: | 16.33 | Buy |
| 20-day EMA: | 16.91 | Buy |
| 50-day EMA: | 17.97 | Sell |
| 200-day EMA: | 20.62 | Sell |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.79 | Sell |
| Relative Strength Index (14 RSI): | 48.85 | Sell |
| Chaikin Money Flow: | -659841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.81 - 19.05) | Sell |
| Bollinger Bands (100): | (16.72 - 20.96) | Sell |
Denali Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 17.14 while DNLI 8-day simple moving average is 15.88, which is a Buy signal.
- The stock price of DNLI is 17.14 while Denali Therapeutics 20-day SMA is 16.90, which makes it a Buy.
- Denali Therapeutics 50-day simple moving average is 18.87 while DNLI share price is 17.14, making it a Sell technically.
- DNLI stock price is 17.14 and Denali Therapeutics 200-day simple moving average is 20.37, creating a Sell signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
41
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Sell
The current Denali Therapeutics [DNLI] share price is $17.14. The Score for DNLI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
2.44B
Price in USD:
17.14
Share Volume:
859.79K
Denali Therapeutics 52-Week Range
52-Week High:
33.31
52-Week Low:
14.56
Sell
41
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 17.14 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 17.14 while DNLI 8-day exponential moving average is 16.33, which is a Buy signal.
- The stock price of DNLI is 17.14 while Denali Therapeutics 20-day EMA is 16.91, which makes it a Buy.
- Denali Therapeutics 50-day exponential moving average is 17.97 while DNLI share price is 17.14, making it a Sell technically.
- DNLI stock price is 17.14 and Denali Therapeutics 200-day simple moving average is 20.62, creating a Sell signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.49 per share, and an increase next year of $0.10 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is -0.79, suggesting Denali Therapeutics is a Sell
- Denali Therapeutics Relative Strength Index (RSI) is 48.85, which suggest Denali Therapeutics is oversold
- The Bollinger Bands (25) for Denali Therapeutics is (15.81 - 19.05), which suggest Denali Therapeutics is a Sell
- The Bollinger Bands (100) for Denali Therapeutics is (16.72 - 20.96), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.